Skip to content

A case records based retrospective study for Chinese patent medicine in the adjuvant treatment of acute coronary syndrome

A case records based retrospective study for Chinese patent medicine in the adjuvant treatment of acute coronary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900024535
Enrollment
Unknown
Registered
2019-07-14
Start date
2019-09-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease angina pectoris

Interventions

Sponsors

Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Male and female aged 35-75 years old; 2. Admission time is September 1, 2014 to September 1, 2019; 3. Patients with acute coronary syndrome in the inpatient department or outpatient department of cardiology, include Unstable angina pectoris and non-ST-segment elevation myocardial infarction, resting angina pectoris, worsening exertional angina pectoris, variant angina pectoris, meet the diagnosis standard of angina pectoris issued by ACC/AHA, and Association of Cardiovascular Diseases of Chinese Medical Association and Editorial Board of Chinese Journal of Cardiovascular Diseases and the dialectical criteria of traditional Chinese medicine.

Exclusion criteria

Exclusion criteria: 1. Combined with other cardiac diseases, neurosis,climacteric syndrome, hyperthyroidism,cervical spondylosis of spinal cord or vertebral artery type,gastroesophageal reflux disease or hiatal hernia and other diseases that may cause chest pain; 2. Patients with acute myocardial infarction, heart failure, myocarditis,cardiomyopathy,severe heart valve disease, liver failure or renal failure,malignant tumor, severe metabolic diseases and other major diseases,as well as patients with angina pectoris with severe symptoms and uncontrollable symptoms; 3. Pregnant women,breast-feeding women or women of childbearing age who have fertility requirements; 4. Psychiatric patients,or cognitive dysfunction; 5. Researchers think there are other situations that are not suitable for participating in the experiment.

Design outcomes

Primary

MeasureTime frame
Angina Symptoms (Degree of Pain, Frequency and Duration of Angina Pectoris, etc.);Dosage and Frequency of Nitroglycerin;Examination of Clinical Biochemical Indexes such as Myocardial Enzyme Combination, Blood Routine, C-reactive Protein, Renal Function and Electrolyte;Carotid Artery Color Doppler Ultrasound, Cardiac Color Doppler Ultrasound and Other Imaging Examinations;

Countries

China

Contacts

Public ContactChunquan Yu

Tianjin University of Traditional Chinese Medicine

ycq-4@163.com+86 18622569428

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026